Login   |  Users Online: 2294 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts

    Article Cited by others

CLINICAL RESEARCH

Randomized placebo-controlled clinical study on enhancement of Medha (intelligence quotient) in school going children with Yahstimadhu granules

Sheshagiri Srihari, Patel Kalpana S, Rajagopala S

Year : 2015| Volume: 36| Issue : 1 | Page no: 56-62

   This article has been cited by
 
1 Data on dose-dependent cytotoxicity of rotenone and neuroprotection conferred by Yashtimadhu (Glycyrrhiza glabra L.) in an in vitro Parkinson's disease model
Gayathree Karthikkeyan, Ashwini Prabhu, Ravishankar Pervaje, Sameera Krishna Pervaje, Prashant Kumar Modi, Thottethodi Subrahmanya Keshava Prasad
Data in Brief. 2021; 39: 107535
[Pubmed]  [Google Scholar] [DOI]
2 Prevention of MEK-ERK-1/2 hyper-activation underlines the neuroprotective effect of Glycyrrhiza glabra L. (Yashtimadhu) against rotenone-induced cellular and molecular aberrations
Gayathree Karthikkeyan,Ravishankar Pervaje,Sameera Krishna Pervaje,Thottethodi Subrahmanya Keshava Prasad,Prashant Kumar Modi
Journal of Ethnopharmacology. 2021; 274: 114025
[Pubmed]  [Google Scholar] [DOI]
3 Identification of Molecular Network Associated with Neuroprotective Effects of Yashtimadhu (Glycyrrhiza glabra L.) by Quantitative Proteomics of Rotenone-Induced Parkinsonís Disease Model
Gayathree Karthikkeyan,Mohd. Altaf Najar,Ravishankar Pervaje,Sameera Krishna Pervaje,Prashant Kumar Modi,Thottethodi Subrahmanya Keshava Prasad
ACS Omega. 2020; 5(41): 26611
[Pubmed]  [Google Scholar] [DOI]

 

Read this article